✦ LIBER ✦

Clinical experience with ciprofloxacin in the USA

✍ Scribed by Arcieri, G. ;August, R. ;Becker, N. ;Doyle, C. ;Griffith, E. ;Gruenwaldt, G. ;Heyd, A. ;O'Brien, B.

Publisher: Springer-Verlag
Year: 1986
Weight: 446 KB
Volume: 5
Category: Article
ISSN: 0722-2211
DOI: 10.1007/bf02013994

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overview of clinical experience with cip

Overview of clinical experience with ciprofloxacin

✍ Ball, A. P. 📂 Article 📅 1986 🏛 Springer-Verlag ⚖ 532 KB

Clinical pharmacokinetics of ciprofloxac

Clinical pharmacokinetics of ciprofloxacin in patients with major burns

✍ A. Lesne-Hulin; P. Bourget; F. Ravat; C. Goudin; J. Latarjet 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 107 KB

Experience with laser safety in the USA-

Experience with laser safety in the USA-a review

✍ David H. Sliney 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 764 KB

Clinical experience with etidronate in o

Clinical experience with etidronate in osteoporosis

✍ P. J. Ryan; I. Fogelman 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 336 KB

Clinical experience with clozapine in Ge

Clinical experience with clozapine in Germany

✍ H. Helmchen 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 505 KB

Clinical experience with the micronucleu

Clinical experience with the micronucleus assay

✍ Dr. Harinder S. Garewal; Lois Ramsey; George Kaugars; Jay Boyle 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 616 KB

Because of the logistical and practical problems that make cancer prevention trials using cancer incidence as an endpoint virtually impossible to conduct for the majority of cancer types, there is a desperate need for valid intermediate markers of cancer risk to serve as surrogate endpoints in chemo